Found: 11
Select item for more details and to access through your institution.
Benefit of plasma exchange with albumin replacement on individual items of the quality of life‐Alzheimer's disease score.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064422
- By:
- Publication type:
- Article
Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1314, doi. 10.1002/alz.12477
- By:
- Publication type:
- Article
Complementary analyses of the AMBAR trial: Individual items of CDR and ADAS‐Cog12 in Alzheimer's disease patients treated with plasma exchange with albumin replacement.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053717
- By:
- Publication type:
- Article
Complementary analyses of the AMBAR trial: Impact of discontinuations, consistency of results across outcomes and additional adjustments: Clinical manifestations: Update on pharmacologic and nonpharmacologic interventions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.043189
- By:
- Publication type:
- Article
Complementary analyses of the AMBAR trial: Impact of discontinuations, consistency of results across outcomes and additional adjustments: Clinical manifestations: Update on pharmacologic and nonpharmacologic interventions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043189
- By:
- Publication type:
- Article
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 10, p. 1412, doi. 10.1002/alz.12137
- By:
- Publication type:
- Article
Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study.
- Published in:
- Journal of Clinical Apheresis, 2023, v. 38, n. 1, p. 45, doi. 10.1002/jca.22026
- By:
- Publication type:
- Article
Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 61, doi. 10.1016/j.trci.2019.01.001
- By:
- Publication type:
- Article
Efficacy and safety evaluation of Fanhdi<sup>®</sup>, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. e23, doi. 10.1111/hae.14453
- By:
- Publication type:
- Article
Impact of therapeutic and low volume plasma exchange on clinical laboratory parameters in patients treated for Alzheimer's disease from the AMBAR study.
- Published in:
- Therapeutic Apheresis & Dialysis, 2023, v. 27, n. 5, p. 949, doi. 10.1111/1744-9987.14002
- By:
- Publication type:
- Article
Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4589, doi. 10.1007/s00259-022-05915-5
- By:
- Publication type:
- Article